Top 50 Biotech VC Funds & Investors in Finland (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Business Finland
VC Fund
|
10 | Finland, United States, United Kingdom | Seed, Grant, Debt Financing | Software, SaaS, Biotechnology | $48k–$11M |
|
Lifeline Ventures
VC Fund
|
9 | Finland, United States, United Kingdom | Seed, Series A | Software, Health Care, E-Commerce | $547k–$20M |
|
Voima Ventures
VC Fund
|
9 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $439k–$18M |
|
Tesi
VC Fund
|
9 | Finland, United States, Switzerland | Series A, Series B | Software, Manufacturing, Health Care | $2.2M–$41M |
|
Finnvera Venture Capital
VC Fund
|
8 | Finland, United States, Switzerland | Seed, Series A | Software, Health Care, Information Technology | $250k–$22M |
|
Butterfly Ventures
VC Fund
|
5 | Finland, Sweden, Norway | Seed, Pre-Seed | Health Care, Software, Information Technology | $110k–$4.4M |
|
Springvest
VC Fund
|
5 | Finland | Series A, Seed | Biotechnology, Health Care, Energy | $3.6M–$53M |
|
Icebreaker.vc
VC Fund
|
4 | Finland, Estonia, Sweden | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $106k–$25M |
|
Stephen Industries
VC Fund
|
3 | Finland, Sweden | Seed, Pre-Seed, Series A | Health Care, Biotechnology, Apps | $330k–$45M |
|
Nordic Foodtech VC
VC Fund
|
3 | Finland, Sweden, Denmark | Seed, Series A | Biotechnology, Life Science, Water | $549k–$18M |
|
Innovestor
VC Fund
|
3 | Finland, Denmark, Sweden | Seed, Pre-Seed | Software, Health Care, Information Technology | $163k–$4.1M |
|
Inventure
VC Fund
|
2 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$23M |
|
Fazer
VC Fund
|
2 | Finland | Series A, Series B | Biotechnology, Food Processing | |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $380k–$4.6M |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$88M |
|
Sitra
VC Fund
|
2 | Finland, The Netherlands | Series A, Series C | Health Care, Biotechnology, Therapeutics | |
|
Sofinnova Partners
VC Fund
|
2 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$102M |
|
Finnish Climate Fund
VC Fund
|
2 | Finland | Debt Financing, Series A | Energy, Renewable Energy, Manufacturing | $2.6M–$14M |
|
EQT Life Sciences
VC Fund
|
2 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.9M–$140M |
|
European Investment Bank
VC Fund
|
2 | Germany, France, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | |
|
VTT Ventures
VC Fund
|
2 | Finland | Seed, Series A | Biotechnology, Manufacturing, Sensor | $460k–$13M |
|
Pontos Group
VC Fund
|
2 | Finland | Genetics, Hospital, Automotive | ||
|
Emerald Technology Ventures
VC Fund
|
1 | United States, Germany, Finland | Series B, Series A | Manufacturing, Software, Energy | $4M–$129M |
|
Illusian Founder Office
VC Fund
|
1 | Finland, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | |
|
Nordea
VC Fund
|
1 | Finland, Sweden, Norway | Debt Financing, Seed | FinTech, Financial Services, Banking | |
|
Wave Ventures
VC Fund
|
1 | Finland, Sweden, Germany | Seed, Pre-Seed | Software, Mobile Apps, Information Technology | |
|
Valio
VC Fund
|
1 | Finland | Series A, Series B | Life Science, Biotechnology | |
|
MTIP AG
VC Fund
|
1 | United States, United Kingdom, Spain | Series A, Series B, Series C | Health Care, Artificial Intelligence, Medical | |
|
Aqua Spark
VC Fund
|
1 | United States, Norway, Israel | Series A, Seed | Biotechnology, Aquaculture, Seafood | |
|
Ananda Impact Ventures
VC Fund
|
1 | Germany, United Kingdom, Finland | Seed, Series A | Health Care, Software, Information Technology | |
|
Keksintösäätiö
VC Fund
|
1 | Finland | Seed | Apps, Health Care, Biotechnology | |
|
Visionplus
VC Fund
|
1 | Finland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Internet | |
|
Novartis Venture Fund
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $4.7M–$105M |
|
Tekes Venture Capital
VC Fund
|
1 | Finland | Genetics, Hospital, Health Care | ||
|
Unifund
VC Fund
|
1 | Finland | Software, Collaboration, Management Consulting | ||
|
The Forum Corporation
VC Fund
|
1 | Finland | Series A | Biotechnology | |
|
Metsola Ventures
VC Fund
|
1 | Finland | Series A | Medical, mHealth, Health Care | $2.2M–$4.8M |
|
Thames Trust
VC Fund
|
1 | United Kingdom, Finland | Seed, Series A, Series B | SaaS, FinTech, Finance | |
|
Valve Ventures
VC Fund
|
1 | Finland | Seed, Series A | Energy, CleanTech, Oil and Gas | $4.4M–$6.7M |
|
XR Invest
VC Fund
|
1 | Finland, United States | Series A, Series C | Medical Device, Sensor, Medical | |
|
Lundbeckfonden Ventures
VC Fund
|
1 | United States, Denmark, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $10M–$95M |
|
Agronomics
VC Fund
|
1 | United States, Finland, Germany | Series A, Seed, Series B | Biotechnology, Food and Beverage, Food Processing | $894k–$55M |
|
Tiger Global Management
VC Fund
|
1 | United States, India, China | Series B, Series A, Series C | Software, FinTech, Financial Services | $8M–$298M |
|
Broadview Ventures
VC Fund
|
1 | United States, Canada, Israel | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
Takoa Invest
VC Fund
|
1 | Finland, Israel | Seed, Series B, Series C | Biotechnology, Mobile, Retail | $483k–$1.3M |
|
Stockholm Techstars Accelerator
VC Fund
|
1 | Israel, Norway, Sweden | Pre-Seed | Pet, FinTech, Finance | $120k–$120k |
|
H&M Group Ventures
VC Fund
|
1 | Sweden, United States, United Kingdom | Series A, Series B | E-Commerce, Fashion, Textiles | $1.9M–$50M |
|
Bridford Investments
VC Fund
|
1 | Finland | Series A | Biotechnology, Food Processing | |
|
Midinvest Management
VC Fund
|
1 | Finland | Seed, Convertible Note | Software, Information Technology, Internet | $193k–$260k |
|
K5 Global
VC Fund
|
1 | United States, United Kingdom, Brazil | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $50k–$50M |
| Access all 50 VC funds in Finland Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Seed, Grant, Debt Financing
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 181
- Round size: Seed $127k–$4.2M; Grant $48k–$11M; Debt Financing $212k–$4.9M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- SSAB —
- Valio — We are Valio Group: the most innovative dairy and food company in the world.
- Jaakko.com — Reinventing the housing market with no agents, more homes, and less fees.
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 178
- Round size: Seed $547k–$5.4M; Series A $2.7M–$20M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $171M in 2023
Portfolio highlights
- ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
- Carbo Culture — We are a project developer with proprietary climate technology. We are building a rapidly scalable biochar carbon removal solution.
- Everywear Games — Metacore is a wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s games are consistently on top ofglobal charts.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 59
- Round size: Seed $1M–$5.5M; Pre-Seed $439k–$2.1M; Series A $3.8M–$18M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
- Quantrol Ox — Building Machine Learning Based Software for Quantum Control with a goal to maximise quantum computer uptime.
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Series A, Series B
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 142
- Round size: Series A $2.2M–$41M; Series B $3.1M–$35M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
- Wirepas — Wirepas offers a standards-based, ultra-reliable mesh connectivity for infrastructure-grade IoT. Proven in millions of devices worldwide.
- MaaS Global — Whim combines all the transportation you need: Public transport, shared cars, bikes, e-scooters, taxis, and more! One app to plan, book, and pay.
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 92
- Round size: Seed $250k–$1.5M; Series A $1.7M–$22M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 86
- Round size: Seed $219k–$2.1M; Pre-Seed $110k–$4.4M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- 10Lines — Explore cutting-edge pavement marking robots for faster, autonomous striping and significant CO2 reduction. Contact us now!
- CooliBlade — Superior power electronics cooling solutions for applications like solar and wind energy, energy storage, EV charging and telecommunications.
- Popit — Popit makes medication connected with a unique, medical grade solution. It tracks medication use automatically and reminds ONLY if you miss. Developed together with healthcare professionals.
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Series A, Seed
- Geography: Finland
Investor stats
- Total investments: 20
- Round size: Series A $3.6M–$53M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Estonia, Sweden
Investor stats
- Total investments: 121
- Round size: Seed $384k–$5.2M; Pre-Seed $106k–$1.3M; Series A $3.1M–$25M
- Lead/follow: 55% lead, 45% follow
- Last fund: May invest from a new fund soon — raised $22M in 2021
Portfolio highlights
- Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- NROC Security — Prevent data leaks, govern shadow AI, prove compliance, and save 50% on GenAI subscriptions
We fund futurebreakthroughs
Show more...Investment focus
- Industry: Health Care, Biotechnology, Apps
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden
Investor stats
- Total investments: 13
- Round size: Seed $1.4M–$8.3M; Pre-Seed $330k–$4.4M; Series A $8.4M–$45M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
- HYPERMINE — Hypermine a novel laser-based mineralogy sensing technology to optimize resource recovery and reduce the negative environmental effects of mining.
- TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more...Investment focus
- Industry: Biotechnology, Life Science, Water
- Stage:Seed, Series A
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 26
- Round size: Seed $549k–$5.5M; Series A $7.4M–$18M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $49M in 2021
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
- Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Denmark, Sweden
Investor stats
- Total investments: 74
- Round size: Seed $507k–$4.1M; Pre-Seed $163k–$2M
- Lead/follow: 62% lead, 38% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 164
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$23M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Omocom — Omocom offers safe, simple and secure insurance for all kind of renting, sharing and re-using, digitally, automated and integrated into the sales flow of the platform
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Fazer Group mission is to create taste sensations. Customer orientation, quality and operations are based.
Show more...Investment focus
- Industry: Biotechnology, Food Processing
- Stage:Series A, Series B
- Geography: Finland
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden
Investor stats
- Total investments: 10
- Round size: Seed $1.1M–$4.6M; Pre-Seed $380k–$837k
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- AIATELLA — Automating medical image analysis
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 121
- Round size: Series A $5.7M–$55M; Series B $14M–$88M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Series A, Series C
- Geography: Finland, The Netherlands
Investor stats
- Total investments: 7
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 298
- Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
The Climate Fund focuses on combating climate change, boosting low-carbon industry and promoting digitalisation.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Manufacturing
- Stage:Debt Financing, Series A
- Geography: Finland
Investor stats
- Total investments: 20
- Round size: Debt Financing $2.6M–$14M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
- Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 168
- Round size: Series A $6.9M–$77M; Series B $8.6M–$103M; Series C $12M–$140M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $266M in 2023
Portfolio highlights
- Neuravi — Neuravi is an early stage company in the large emerging neurointerventional device market. Led by a team experienced in endovascular device development and global commercialization, the company's initial technology platform addresses acute ischemic stroke. In collaboration with international researchers and clinicians, the company seeks todevelop new understanding that will drive innovative solutions to treat this challenging and devastating disease. Neuravi was founded in 2009 and is headquartered in Galway, Ireland, home to many of the world’s leading medical device companies.
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Mosanna Therapeutics — Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: Germany, France, The Netherlands
Investor stats
- Total investments: 247
- Lead/follow: no public data
Portfolio highlights
- Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
- Greenlight Biosciences — Next Generation Crop Protection
- Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Sensor
- Stage:Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 24
- Round size: Seed $460k–$6M; Series A $1.7M–$13M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more...Investment focus
- Industry: Genetics, Hospital, Automotive
- Geography: Finland
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
- Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Emerald Technology Ventures specializes in clean technology venture capital. Emerald focuses on the areas of energy, water, and materials. , Emerald manages several venture capital funds and venture capital portfolio mandates.
Show more...Investment focus
- Industry: Manufacturing, Software, Energy
- Stage:Series B, Series A
- Geography: United States, Germany, Finland
Investor stats
- Total investments: 91
- Round size: Series A $4M–$14M; Series B $5.5M–$129M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $212M in 2022
Portfolio highlights
- Vytal — Start the Packaging Revolution! We are offering smart & reusable To-Go Packaging-as-a-Service to gastronomy clients & consumers.In Germany the consumption of take-away, convenience and delivery food & drinks is responsible for about 281 kilotons of single-use packaging waste for immediate consumption and is growing at double digitrates. Most of the time, To-Go food containers, snack boxes or coffee cups have a very short life-span of only 30 minutes after which they are tossed into trash (or litter parks, beaches & the ocean). This is not only a giant waste of economic resources as each single use costs between 15 and up to 0,60€ for a stable bowl/box with a lid. It is a horrendous waste of environmental resources (wood, water, crude oil, metals & energy) that are used to produce this packaging. Therefore, a single use packaging not weighing more than 30 grams can easily come with an ecological backpack of more than 8 kilograms when taking into account all the resources used in production (material intensities taken from Wuppertal Institute for Climate, Environment and Energy). Looking at GHG emissions, the picture is similarly bleak: Using CO2 emission factors and the detailed material mix of the single-use packaging waste analyzed by NABU (German Nature and Biodiversity Conservation Union), the 281 thousand tons waste from To-Go consumption generated around 556 thousand tons of CO2 or the equivalent of 195k passenger cars per year (assuming an average distance travelled of 15,000km). With the expected rise of take-away, convenience and delivery food, the related emissions are expected to increase at double digit rates as waste volume is expected to increase and as we saw a shift to plastics relative to cardboard or other materials. While there is a growing awareness of the problem, especially in Germany, there is no scalable solution yet and the commonly used alternative of nature-based & ‘biodegradable’ materials like bagasse or PLA also require many resources for production & transport, and have to be incinerated or go to landfill after use as there is currently no way to compost them.
- Cajo Technologies — Laser Marking - Cajo turnkey solutions for traceability & product markings. Easy to use & optimized for industrial production processes.
- NLM Photonics — Data centers consume enormous amounts of power; our faster, energy-efficient electro-optic modulation solution moves data across the internet.
Illusian is the Founder Office of people who have founded and scaled companies like Supercell, Zalando, Wolt, Aiven, Pigment, and Smartly. While the group is still busy running their businesses, they've aligned their networks, capital, and expertise to simultaneously support the next generation of builders.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Finland, United States, Germany
Investor stats
- Total investments: 45
- Lead/follow: no public data
Portfolio highlights
- Ever (evercars.com) — Ever is a technology and automotive company that helps its customers buy and sell high-quality electric vehicles. The company is based out of San Francisco, backed by leading investors, and led by former tech & automotive professionals from Uber, Lithia, Penske, Rivian, Carvana, Tesla, Lucid, TrueCar, Longo Toyota, Boston Consulting Group, J.P.Morgan, Lyft, Shopify, Flexport, Golden Gate Capital, and more.
- IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
- Ovido — Ovido company specialises in supply chain and product data automation, with a focus on providing full product traceability and the establishment of Digital Product Passports (DPPs).
Nordea Bank is Denmark's second-largest bank and counts every fourth Dane among its customers. Through their nationwide network of some 340 branch offices and a broad range of self-service facilities, they are able to offer you a full scale of financial products and services, including Netbank, Online Investment, telephone banking and cashdispensers.
Show more...Investment focus
- Industry: FinTech, Financial Services, Banking
- Stage:Debt Financing, Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Tibber — Tibber is a digital electricity supplier that offers smart solutions to minimize their customers’ consumption and costs. Its vision is to make sustainable energy consumption simple and affordable for all households. Tibber's mission is to reduce the residential electricity consumption for European households by 20 %. Founded in Norway andSweden in 2016, the company has expanded its offer to Sweden and Germany where it powers hundreds of thousands of homes. Tibber replaces traditional utilities with smart technology, supplying its customers with renewable energy at fair and transparent prices. In addition, its app provides real-time analytics into energy usage, and pairs with a variety of smart home devices to reduce electricity consumption at home. The company sells tech-gadgets in their online store and recently was licensed to balance the main power grid in Sweden with EVs.
- Statzon — Make data-driven plans & faster decisions with a simple access to +1M datasets & market reports about 8,000 topics from +200 trusted data providers.
- Get It Done Now — GIDN is a Nigerian Fintech Company targeting medium and low income population for Loans and Financial products. GIDN has in addition a cashless, mobile based community marketplace, with more than 5k members, and aims to regulate the informal economy and facilitate the purchase of Services and Digital Products.
Founded in 2016, Wave Ventures is the largest student-run VC in Europe, backed by Nordic unicorn founders, investing in Gen Z entrepreneurs at the earliest stage. We operate both from Finland and Sweden with a team of five people from the top universities in the region.
Show more...Investment focus
- Industry: Software, Mobile Apps, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Germany
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- Bought — Everything you've bought, automatically ready for resale.
- Sustashift — Sustashift offers a comprehensive legal CSRD reporting tool, providing tailored audit templates and automated XBRL tagging to streamline compliance and reduce manual reporting efforts.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
We are Valio Group: the most innovative dairy and food company in the world.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A, Series B
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 20
- Lead/follow: no public data
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Aqua-Spark is an investment fund with a focus on sustainable aquaculture businesses around the world. The small-to-medium enterprises (SMEs) they invest in are working toward the production of safe, accessible aquatic life, such as fish, shellfish and plants, in ways that do not harm their oceans. Their investors value the fact that each investmentaims to create triple impact—specifically, each investment is chosen for its potential to generate significant financial returns while also activating positive environmental and social outcomes.Aqua-Spark believes that committing to a long-term vision is the way to realize effective and lasting impact results. When it comes to investments, they do not seek quick exits; instead, they look for entrepreneurs who strive to build and scale toward the future, who see their business as major economic opportunities that can also help solve looming environmental and food security challenges over the long-term. As an essential of each investee, Aqua-Spark seeks sustainability.
Show more...Investment focus
- Industry: Biotechnology, Aquaculture, Seafood
- Stage:Series A, Seed
- Geography: United States, Norway, Israel
Investor stats
- Total investments: 40
- Lead/follow: no public data
Portfolio highlights
- Protix — Discover how Protix is revolutionizing the food system by converting organic waste into nutritious insect-based ingredients for a sustainable future.
- XpertSea — XpertSea is a Canadian technology company that's transforming how the global aquaculture industry farms seafood to help feed the world. Combining smart aquaculture equipment with a farm management platform, our collaborative solution uncovers actionable insights driven by artificial intelligence. These insights enable farmers and industryexperts to optimize feed efficiency, reduce environmental waste, take preventive actions against diseases and use data to bring transparency and knowledge to the entire supply chain. With customers in over 50 countries, we’re using Canadian ingenuity to make aquaculture profitable and sustainable.
- Proteon Pharmaceuticals — Proteon Pharmaceuticals serves livestock and aquaculture farms that aim for high-quality and sustainable protein production.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- Elio — Putting leading scientific data into context, to enable others to respond to climate change’s dynamism and act on solutions with confidence.
- Ocean Ledger — Precision analytics to design, implement & monitor coastal mitigation and adaptation.
- NatureMetrics — NatureMetrics is the World-Leading provider of Biodiversity monitoring data, using eDNA surveys, metabarcoding & more. Book your demo today!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Keksintösäätiö
Show more...Investment focus
- Industry: Apps, Health Care, Biotechnology
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
WE HELP YOU TO GROW FASTER!
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 74
- Lead/follow: no public data
Portfolio highlights
- Pebble — Pebble is a electric vehicle manufacturing startup.
- Transfluent — Professional translations for all business needs. Fast. Easy.
- BetterDoctor — Our provider network software solutions & services provide unmatched tools & insights for you. Discover how you can measure, manage, monitor & model.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 209
- Round size: Series A $4.7M–$81M; Series B $11M–$105M; Series C $9M–$75M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
- Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
- Amphista Therapeutics — We are purposefully designing the next generation of targeted protein degraders to transform the lives of patients with intractable diseases.
Tekes Venture Capital invests in companies in their early stages of development. Its purpose is to develop Finland's venture capital market.
Show more...Investment focus
- Industry: Genetics, Hospital, Health Care
- Geography: Finland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Unifund Jyväskylä Ltd is to support the start-up of research-based businesses.
Show more...Investment focus
- Industry: Software, Collaboration, Management Consulting
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
- PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
Fortum Oyj is a global learning and development firm specializing in strategy execution for companies in a broad array of industries.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Metsola Ventures
Show more...Investment focus
- Industry: Medical, mHealth, Health Care
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Series A $2.2M–$4.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Thames Trust
Show more...Investment focus
- Industry: SaaS, FinTech, Finance
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Finland
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- STEM — For makers, learners, and players. Creative computing projects, stories, and more.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
- ABAKA Holdings — Fintilect delivers hyper-personalized digital banking solutions to financial institutions, empowering them to adapt, respond and prosper. Find out more.
Valve Ventures is a Helsinki-based angel and early-stage venture investor.
Show more...Investment focus
- Industry: Energy, CleanTech, Oil and Gas
- Stage:Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 6
- Round size: Series A $4.4M–$6.7M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
- Woodio — Woodio is a digital designing agency.
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.
Show more...Investment focus
- Industry: Medical Device, Sensor, Medical
- Stage:Series A, Series C
- Geography: Finland, United States
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 65
- Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $16M–$53M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- Notify Therapeutics — Notify Therapeutics develops therapies for the treatment of infertility. By targeting the early and hormone-independent phase of egg maturation, the company aims at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy. It utilizes drug-inducing factors that regulate the intracellular AKTpathway and target the early and hormone-independent phase of egg maturation for the treatment.
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Finland, Germany
Investor stats
- Total investments: 44
- Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- BlueNalu — BlueNalu's mission is to be the global leader in cellular aquaculture, providing consumers with great tasting, healthy, safe, and trusted seafood products that support the sustainability and diversity of our oceans.
- Onego Bio — Onego Bio is a cell ag company, specialized in animal-free egg white protein. We produce bioalbumen with an innovative precision fermentation process.
- Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Founded in 2001, Tiger Global Management, LLC (“Tiger Global”) is a New York-based investment firm pursuing a long-term approach to investing in leading, global public and private companies that leverage technological innovation. Tiger Global’s public equity business includes fundamentally oriented long/short, long-focused and crossoverstrategies, targeting investments in high-quality, public growth companies. The private equity business invests in early through late stage companies that pursue innovative approaches to new and existing industries, building on over 20 years of experience investing in hundreds of businesses in more than 30 countries with more than 90 portfolio company IPOs. With a strong track record investing across sectors and stages, Tiger Global aims to be a thought partner to companies and their management teams across their lifecycle in public and private markets. The Firm’s mission is to generate world-class returns for its investors and to do so in a way that makes its employees, partners and portfolio companies proud.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series B, Series A, Series C
- Geography: United States, India, China
Investor stats
- Total investments: 861
- Round size: Series A $8M–$50M; Series B $17M–$130M; Series C $25M–$298M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely still investing — raised $2.2B in 2024
Portfolio highlights
- Chaayos — Your one stop shop for all your Chai Cravings. Easy way to buy out Masala Tea, Instant Tea, Green Teas and Tea Gifts.
- Progcap — Progcap is revolutionising the way financial access is delivered to underserved segments of the Indian retail economy, through specialized financing and technology products that empower small and medium businesses (SMBs) to progress without obstacles.
- G.O.A.T Brand Labs — Purpose G.O.A.T is mono-maniacally focussed on the audacious goal of Making Indian D2C brands world...
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 76
- Round size: Seed $1M–$9.8M; Series A $1M–$20M; Series B $7M–$45M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- FineHeart — Our mission is to address the unmet need of patients with sever heart failure
- 480 Biomedical — 480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown,Massachusetts.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
Takoa Invest is a Finnish family-owned investment company that owns and develops companies and properties with growth potential in Finland and abroad. Takoa Invest is a Finnish family-owned investment company. It owns and develops companies and properties with growth potential in Finland and abroad.
Show more...Investment focus
- Industry: Biotechnology, Mobile, Retail
- Stage:Seed, Series B, Series C
- Geography: Finland, Israel
Investor stats
- Total investments: 4
- Round size: Seed $483k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- IndoorAtlas — Discover the power of indoor positioning technology with IndoorAtlas. Build innovative indoor location-based solutions using our cross-platform SDK. Explore case studies and start developing today.
The Stockholm Techstars Accelerator invests in early-stage, high-growth companies looking to build and expand in the Nordic-Baltic startup ecosystem.
Show more...Investment focus
- Industry: Pet, FinTech, Finance
- Stage:Pre-Seed
- Geography: Israel, Norway, Sweden
Investor stats
- Total investments: 7
- Round size: Pre-Seed $120k–$120k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- goscore — Fair human credit scoring, credit check, and assessment for you
- Terrawaste — TerraWaste is a next-generation chemical recycling company that turns non-recyclable waste into value by creating new, climate-positive materials with a pollution-free process. TerraWaste focuses on lowering the level of need for virgin oil extraction by recycling plastics with chemical recycling technology 'htloop' into high-qualityclimate-positive crude oil, biochar, and high-value chemicals to support companies globally to become more sustainable and circular. Our technology (htloop) is developed on a process developed in the laboratory for over 20 years and hasn’t been commercialized until recently. TerraWaste is the first company to use HTL to recycle plastic waste and turn it into new plastic products. The unique thing is the state-of-the-art technological system that will recycle waste in a continuous-flow system, at the same time reusing heat and water in a loop, that way dramatically decreasing energy consumption. Our process is pollution free, and we produce carbon-negative output materials, that way offsetting other, carbon-heavy industries.
- Five Letter Foods — Real food for dogs. Ultra-processed junk food is boring and makes your dog sick. Our meal kits have a full swing of variety. Death to kibble.
H&M Group Ventures is the venture capital arm of the H&M Group.
Show more...Investment focus
- Industry: E-Commerce, Fashion, Textiles
- Stage:Series A, Series B
- Geography: Sweden, United States, United Kingdom
Investor stats
- Total investments: 55
- Round size: Series A $1.9M–$50M; Series B $14M–$40M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Centra — Centra is part of creating the next generation of brands, with a direct-to-consumer and wholesale e-commerce software for global brands. Brands across Scandinavia and the world trust Centra to seamlessly connect people to products. We're a medium-sized company with offices in Stockholm, Sweden, Wroclaw, Poland and New York City, USA.
- Colorifix — Colorifix is a biotechnology company that has pioneered the first entirely biological process to produce, deposit and fix pigments onto textiles. Using a synthetic biology approach, it offers a radically different solution to incumbent dyeing technologies that entirely cuts out the use of harsh chemistry and leads to huge reductions in waterconsumption. Colorifix’s investors include Cambridge Enterprise, H&M, Mills Fabrica, Primera Impact and Sagana, whose collective backing is funding its expansion. For more information, visit www.colorifix.com
- Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.
Bridford Investments
Show more...Investment focus
- Industry: Biotechnology, Food Processing
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
- Touchlight Genetics — Founded in 2008, Touchlight brings together a highly talented scientific and drug development team supported by an experienced board.Founder and CEO Jonny Ohlson has assembled a dynamic management team, including Clive Dix, Non Executive Chairman, and John Tite, Executive Head of Research (formerly founding CEO of Bicycle Therapeutics), withsubstantial experience in growing life science companies and particularly in DNA vaccines. Touchlight is supported by a group of Non-Executive Directors, who bring a wealth of healthcare and entrepreneurial experience.Led by experienced drug pharmaceutical scientists Neil Porter and Jill Makin, Touchlight’s scientific team- some of the brightest talents in the UK industry- has successfully established and patented the proTLx™ synthetic DNA platform as well as successfully establishing the first therapeutic proof-of-principle through collaboration with leading academic partners.The company has established strong collaborative links with academic laboratories worldwide including Imperial College London, Southampton University, Queen’s University Belfast and the University of Pennsylvania in the US.
Midinvest Management is a Finnish private equity firm specialized in ownership arrangements for small- and medium-sized enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Convertible Note
- Geography: Finland
Investor stats
- Total investments: 4
- Round size: Seed $193k–$260k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
- Quosis — As of March 18, 2008, Quosis Oy was acquired by Proactum Oy. Quosis Oy operates as an open source software service company. It offers open-source based solutions and services, including portal solution for managing organization’s information and services; content management for gathering, sharing, saving, and producing information; businessprocess management for automating, monitoring, managing, and improving key processes; integration of information systems; and instant messaging for improving the organizational information exchange. The company also offers open source consultation and software development services. It serves the paper industry. The company was founded in 2004 and is headquartered in Jyvaskyla, Finland.
- Howspace — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
Backing category-defining companies from inception to IPO.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Brazil
Investor stats
- Total investments: 174
- Round size: Seed $100k–$10M; Pre-Seed $50k–$3.4M; Series A $75k–$50M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Balsa — Balsa Build is a next generation project management tool that helps you ship faster by providing better visibility and coordination across existing tools like Jira and Github in one central location.
- Kled AI — Meet Nitrility, The World's First Intellectual Property Marketplace.
- Chain — Chain is a pop-up restaurant that accepts deliveries and offers popular chain restaurant dishes.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech VC Funds in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Finland Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!